Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer ...
Breadcrumb Trail Links GlobeNewswire Author of the article: Published Oct 04, 2024 • 6 minute read Article content Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in advanced or metastatic solid tumors …